LUP Statistics
Record
- Title
- Killing of CLL and NHL cells by rituximab and ofatumumab under limited availability of complement.
- Type
- Journal Article
- Publ. year
- 2013
- Author/s
- Okroj, Marcin; Eriksson, Ingrid; Osterborg, Anders; Blom, Anna
- Department/s
- Protein Chemistry, Malmö; BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- In LUP since
- 2016-04-01
Downloads
| Total | This Year | This Month |
| 437 | 10 | 2 |
United States of America  |
266 (61%) |
Germany  |
47 (11%) |
China  |
23 (5%) |
Sweden  |
18 (4%) |
India  |
10 (2%) |
France  |
10 (2%) |
United Kingdom of Great Britain and Northern Ireland  |
9 (2%) |
Poland  |
5 (1%) |
Hong Kong (China)  |
5 (1%) |
South Korea  |
4 (1%) |
Ireland  |
4 (1%) |
Ukraine  |
3 (1%) |
Taiwan (China)  |
3 (1%) |
Netherlands (Kingdom of the)  |
2 (0%) |
Russian Federation  |
2 (0%) |
Slovenia  |
2 (0%) |
Iran  |
2 (0%) |
Japan  |
2 (0%) |
Switzerland  |
2 (0%) |
Denmark  |
1 (0%) |
Portugal  |
1 (0%) |
Estonia  |
1 (0%) |
Czechia  |
1 (0%) |
Australia  |
1 (0%) |
Belarus  |
1 (0%) |
Greece  |
1 (0%) |
Latvia  |
1 (0%) |
Canada  |
1 (0%) |
Macedonia  |
1 (0%) |
Egypt  |
1 (0%) |
Finland  |
1 (0%) |
Singapore  |
1 (0%) |
Spain  |
1 (0%) |
South Africa  |
1 (0%) |
Israel  |
1 (0%) |
Iraq  |
1 (0%) |